Tesamorelin

Tesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH). It is designed to bind to growth hormone-releasing hormone receptors in the anterior pituitary, where it stimulates the physiological release of endogenous growth hormone through pulsatile signaling. As a stabilized analog of naturally occurring GHRH, tesamorelin has been the subject of scientific and clinical research investigating its pharmacological characteristics, receptor interactions, endocrine signaling pathways, pharmacokinetics, and mechanism of action. Ongoing research continues to examine its biological activity and physiological effects within controlled laboratory and clinical study environments.